Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "Sepsis"

15 News Found

Good microbiome and probiotics key to good health
Healthcare | April 04, 2022

Good microbiome and probiotics key to good health

The symposium was organized by the Gut Microbiota and Probiotic Science Foundation (India) and Medanta Institute of Education and Research, Gurugram, and Amity University, Gurugram


New spesolimab data show promising results in patients with generalised pustular psoriasis flares
Biotech | March 28, 2022

New spesolimab data show promising results in patients with generalised pustular psoriasis flares

Clinical improvements were consistent across patient subgroups including age, gender, ethnicity, and IL-36 gene mutation status


Amrita University launches wearable device for home monitoring of glucose and BP
Digitisation | March 02, 2022

Amrita University launches wearable device for home monitoring of glucose and BP

Patients can use the wearable, non-invasive device to measure six body parameters including blood glucose, blood pressure, heart rate, blood oxygen, respiratory rate and 6-lead ECG, from the comfort of their home


Zydus to begin Phase II (a) clinical trial of ZYIL1 in Australia
Biotech | December 13, 2021

Zydus to begin Phase II (a) clinical trial of ZYIL1 in Australia

It is a novel oral NLRP3 inflammasome inhibitor


Boehringer Ingelheim announces EMA marketing authorisation for spesolimab
Drug Approval | October 29, 2021

Boehringer Ingelheim announces EMA marketing authorisation for spesolimab

Generalized pustular psoriasis is characterized by episodes of widespread eruptions of painful, sterile pustules